|
NKTR Nektar Therapeutics 906709 |
| Balance Sheet |
|
Current Assets
|
286,481,000 |
|
Assets
|
307,966,000 |
|
Current Liabilities
|
67,583,000 |
|
Liabilities
|
259,082,000 |
|
Equity
|
48,884,000 |
|
Shares Out
|
184,079,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-129,522,000 |
|
Investing Cash Flow
|
82,356,000 |
| Market Analysis |
Market Cap
|
235,621,626 |
|
Price
|
0.89 |
|
BVPS
|
0.27 |
|
PB
|
3.31 |
|
EPS
|
-0.90 |
|
PS
|
2.44 |
|
FCF
|
-47,166,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NKTR documents filed with the SEC.
NKTR Filings
Clear
